Monocyte-derived macrophages mostly reside in a resting, G0 state, expressing high levels of 20 dephosphorylated, active SAMHD1. We have previously shown that macrophages can re-21 enter the cell cycle without division, into a G1-like state. This cell cycle re-entry is 22
accompanied by phosphorylation of the dNTP hydrolase/ antiviral restriction factor 23 SAMHD1 at T592 by the cyclin-dependent kinase CDK1. HIV-1 successfully infects 24 macrophages in G1 through exploiting this naturally occurring window of opportunity where 25 SAMHD1 antiviral activity is de-activated. 26
27
Here we demonstrate for the first time that LPS activation of the pathogen associated 28 molecular pattern (PAMP) receptor TLR4 induces G0 arrest in human macrophages. We 29
show this G0 arrest is MyD88-independent and therefore NFkB independent. Furthermore, 30 the effect of TLR4 activation on cell cycle is regulated by (a) the canonical IFN-dependent 31 pathway following TBK1 activation and IRF3 translocation and (b) an IFN-independent 32 pathway that occurs prior to TBK1 activation, and that is accompanied by CDK1 33 downregulation, p21 upregulation and SAMHD1 dephosphorylation at T592. Furthermore, 34 we show by siRNA knockdown of SAMHD1 that the interferon independent pathway 35 activated by TLR4 is able to potently block HIV-1 infection in macrophages specifically via 36 SAMHD1. Finally, ingestion of whole E. Coli and TLR4 activation by macrophages also 37 activates SAMHD1 via the interferon independent pathway. 38
Together, these data demonstrate that macrophages can rapidly activate an intrinsic cell arrest 39 and anti-viral state by activation of TLR4 prior to IFN secretion, thereby highlighting the 40
Introduction 46
Macrophages are the first line of defence against invading pathogens, sensing through 47 pathogen recognition receptors (PRRs) and initiating innate and adaptive responses. The most 48 studied PRRs are Toll-like receptors (TLRs), expressed in monocytes, macrophages and 49 dendritic cells. They play a fundamental role in recognition of pathogen-associated molecular 50 patterns expressed on infectious agents, and subsequently initiate a series of inflammatory 51 events that depend upon the MyD88 and/or TRIF signalling pathways 1 . Amongst TLRs, 52 TLR4 acts as a receptor for lipopolysaccharide (LPS), a component from the wall of gram-53 negative bacteria 2 . Once activated it triggers a well characterised downstream-signalling 54 cascade involving multiple signalling components, culminating in the activation of 55 transcription factors, such as NFkB and IRFs, which, in turn induce various immune and pro-56 inflammatory genes 3 . 57 58 Many studies in the past have shown that LPS has a potent inhibitory activity against HIV-1 59 infection 4-10 . LPS has been shown to down-regulate receptors for HIV-1 entry and impair 60 early steps of viral life cycle 5,11,12 . The mediators of HIV-1 suppression by LPS-stimulated 61 MDM are mostly secreted -chemokines and interferons (IFN) 4,7,9,11 . However, some data 62 suggest that IFN release by LPS-stimulated macrophages/dendritic cells might not be the 63 main mediator of HIV-1 suppression 9,10 . The diverse data on effect of LPS in HIV-1 64 infection suggests multiple anti-HIV mechanisms, consistent with up-regulation of an array 65 of HIV-1 restriction factors 7,10,13 by IFN in LPS-stimulated macrophages and dendritic cells. 66 67 Terminally differentiated myeloid cells and resting T cells express SAMHD1, a 68 deoxynucleotide-triphosphate (dNTP) hydrolase which restricts HIV-1 reverse transcription 69 (RT) through decreasing levels of dNTPs 14, 15 . SAMHD1 phosphorylation at position T592 70 mediated by cyclin-dependent kinases CDK1/2 16,17 impairs its dNTP hydrolase activity in 71 actively dividing cells and allows viral DNA synthesis to occur 16, 18 . SAMHD1 in its 72 dephosphorylated form is active against HIV-1 and known to block infection 16, 17, 19, 20 . 73
74
Our group recently showed that SAMHD1 restriction capacity can be manipulated in 75 monocyte-derived macrophages (MDM). We demonstrated that macrophages, cells normally 76 residing in a G0/terminally differentiated state can re-enter the cell cycle into a G1-like 77 phase, expressing certain cellular cell cycle factors, including CDK1 that is known to 78 phosphorylate and deactivate the antiviral activity of SAMHD1 19,21 . 79 80 Type-I interferons are known to lead to dephosphorylation/activation of SAMHD1 in MDM 81 16, 22 . Whilst it has been proposed that LPS-stimulated macrophages can mediate HIV-1 82 restriction through IFN secretion, the role of SAMHD1 has not been established. 83
84
Here we show that TLR4 activation by bacterial LPS can mediate HIV-1 inhibition through 85 regulation of SAMHD1 in an IFN-independent manner, as well as via the canonical IFN 86 dependent pathway. We show that this IFN-independent pathway is MyD88-independent, 87 occurring prior to TBK1 activation, and resulting in p21 upregulation and G0 arrest with 88 SAMHD1 dephosphorylation. This is the first demonstration that TLR4 activation can 89 directly induce G0 arrest in human macrophages, adding to growing evidence that G0 arrest 90 is a conserved and important response to danger signals even in cells classically viewed as 91 being terminally differentiated. 92
94
Results 95
Interferon-independent SAMHD1 dephosphorylation and HIV-1 blockade in 96 macrophages following TLR4 activation 97
We used human monocyte derived macrophages (MDM) to study the effect of LPS on 98 permissivity to HIV-1 infection. Macrophages were exposed to 10ng/ml LPS for 18h and 99 infected with VSV-G pseudotyped HIV-1 expressing GFP. LPS treatment completely 100 inhibited HIV-1 infection of MDM, accompanied by activation/dephosphorylation of 101 SAMHD1 at T592 ( Fig.1A,B ). 102
We next confirmed that the LPS effect on HIV-1 infection was directly through TLR4 103 activation ( Fig.1C ). We used the TLR4 inhibitor TAK242 that in the presence of LPS was 104 able to rescue HIV-1 infection of MDM and prevent SAMHD1 activation/dephosphorylation 105 ( Fig.1D ). TAK242 also prevented translocation of NFkB and IRF3 into nucleus in the 106 presence of LPS, confirming TLR4 inhibition (Fig. 1C ,E). 107 TLR4 activation stimulates production of interferons (IFN). In order to understand if IFN 108 plays role in SAMHD1 activation/dephosphorylation after TLR4 activation as recently 109 published 16,22 , we used the JAK1/2 inhibitor Ruxolitinib (RUXO) that inhibits IFN signalling 110 ( Fig.1C ) 23 . The inhibitor of IFN signalling could not restore infection and failed to reverse 111 SAMHD1 phosphorylation at T592, suggesting that regulation of SAMHD1 phosphorylation 112 is largely independent of IFN ( Fig.1F ). Importantly, RUXO had no effect on nuclear 113 IRF3/NFkB translocation following LPS addition ( Fig.1G ). 114
Next, we used the TBK1 inhibitor BX795 (Fig.1C ,H,I) that blocks the phosphorylation, 115 nuclear translocation, and transcriptional activity of IRF3 and production of interferon in 116 response to TLR3 and TLR4 agonists 24 (Fig.1I ). BX795 treatment also failed to restore 117 infection and SAMHD1 phosphorylation after LPS addition ( Fig.1H ), confirming that 118 SAMHD1 dephosphorylation/activation is IFN-independent and is mediated upstream from 119 TBK1. 120
121

SAMHD1 activation following TLR4 engagement is MyD88 independent 122
Tenascin-C (TNC) is an extracellular matrix protein which expression is rapidly induced at 123 the site of infection or injury where it triggers inflammation by activating TLR4 in different 124 cells including macrophages 25 . This TLR4 activation is specifically mediated through the 125
MyD88-dependent pathway 26 ( Fig. 2A ). TNC effectively activated the MyD88 dependent 126 pathway in MDM, which was confirmed by detectable translocation of NFkB but absence of 127 nuclear IRF3 ( Fig. 2B ) and by production of cytokines into culture media after treatment with 128 LPS and TNC ( Fig.2C ). Importantly, when MDM were treated with TNC, no SAMHD1 129 dephosphorylation or HIV-1 inhibition was detected ( Fig. 2D ). From these experiments we 130 conclude that LPS activates TLR4 and blocks HIV-1 infection in a MyD88-independent 131 pathway, culminating in dephosphorylation of SAMHD1. 132
133
TLR4 engagement results in interferon-independent G0 arrest in macrophages 134
We have shown previously that macrophage entry to a G1-like state is accompanied by an 135 increase in certain cell cycle associated proteins such as MCM2 and CDK1, as well as 136 phosphorylation of SAMHD1 at T592 that confers increased susceptibility to HIV-1 infection 137 19,21 . LPS treatment resulted in a decrease of MCM2 expression and as expected, SAMHD1 138 dephosphorylation at T592 (Fig.3A, S1A ,B). These results suggest that LPS treatment led to 139 cell arrest in macrophages where SAMHD1 is activated and can block HIV-1 infection as 140 shown in Fig.3A,B . Crucially, the TLR4 inhibitor TAK242 completely reversed the cell 141 arrest and SAMHD1 phosphorylation changes, restoring HIV-1 infection. As expected, 142 blocking IFN signalling in macrophages by treatment with RUXO or TBK1 inhibitor BX795 143 could not restore cell cycle changes, SAMHD1 phosphorylation and HIV-1 infection 144 ( Fig.3A,B) . Remarkably, addition of TNC, molecule that activates TLR4 exclusively via the MyD88-dependent signalling pathway, had no effect on cell cycle in MDM (Fig.3C ). These 146 data strongly suggest that HIV-1 restriction is mediated through G0 arrest that is uncoupled 147 from IRF3 signalling. 148
We hypothesised that the LPS induced G0 arrest would be regulated by expression of 149 negative cell cycle regulators such as p21 or p27. Indeed, immunoblotting confirmed that the 150 decrease in CDK1 and MCM2 after LPS treatment was accompanied by increased p21 levels 151 ( Fig.3D ). As we were unable to detect p27 expression in immunoblot we next sought to 152 further characterise the cell cycle program changes triggered by LPS in MDM, using a panel 153 of cell cycle associated transcripts ( Fig.3E ,F). Statistically significant decreases were 154 observed in transcripts associated with cell cycle progression: CDK1, cyclin E2, cyclin B1, 155 E2F1, MCM2 transcripts compared to the untreated control (set to 1). A small but significant 156 increase was observed for SAMHD1 and WIF1 transcripts, and also for transcripts associated 157 with G0 arrest or G0 state: CDK2, RB1, p27 and p21. These data show that the macrophage 158 cell cycle program is impacted by TLR4 engagement, and are the first evidence of While G0 arrest was observed after both LPS and exogenous IFN addition, based on 174 expression levels of cell cycle associated transcripts, RUXO was unable to rescue G0 arrest 175 caused by LPS/TLR4 activation but completely rescued G0 arrest after addition of exogenous 176 IFN ( Fig.4A,B ). This confirms redundancy of pathways activated by TLR4 that lead to G0 177 arrest. In concordance with these results RUXO failed to restore HIV-1 infection from the 178 effect of LPS but completely rescued HIV-1 infection after exposure to exogenous IFN 179 ( Fig.4C ). These data were confirmed by using an IFN receptor antibody instead of RUXO 180 ( Fig.4D ). As a control the TLR4 inhibitor TAK242 rescued cell cycle and HIV-1 infection 181 after LPS treatment. As expected, TAK242 could not rescue either after IFN treatment. 182
We conclude existence of two independent pathways that are responsible for G0 arrest in 183 MDM, both of which are able to potently block HIV-1 infection. G0 arrest being the first 184 early block to HIV-1 infection while IFN production representing a second wave. 185 186 SAMHD1 is directly responsible for the interferon independent HIV-1 blockade 187 following TLR4 activation 188
We have shown previously that the restriction of HIV-1 infection in G0 MDM can be 189 completely lifted by SAMHD1 depletion 19 . Our experimental system here involves use of 190 MDM predominantly in G1, where SAMHD1 is deactivated/phosphorylated. To confirm that 191 SAMHD1 dephosphorylation/activation is responsible for block to HIV-1 infection after 192 TLR4 activation we employed SAMHD1 knock-down (KD) (Fig.5) . 193
We knocked-down SAMHD1 expression in human MDM using siRNA and infected MDM 194 in the presence or absence of LPS in four different donors ( Fig.5A ). SAMHD1 KD lifted HIV-1 block in the presence of LPS, though as predicted from data in figure 1, full rescue of 196 infection required addition of RUXO ( Fig.5B ). Immunoblot confirmed 80% SAMHD1 KD 197 with no effect on the cell cycle marker MCM2 (Fig.5C ). We conclude that SAMHD1 plays a 198 key role in the TLR4 mediated antiretroviral state in human macrophages. 199
200
Gram-negative bacteria induce TLR4 activation and G0 arrest in human MDM 201
The pHrodo™ E. coli BioParticles™ are inactivated, unopsonized E. coli (K-12 strain) 202
(pHrodo) which function as sensitive, fluorogenic particles for the detection of phagocytic 203
ingestion. We incubated pHrodo with MDM in the presence or absence of different inhibitors 204 for 1h at 37˚C (Fig.6A ). Unbound pHrodo was washed of and cell incubated overnight when 205 cell supernatants were collected for cytokine detection (Fig.6B ) and MDM were infected with 206
HIV-1. Firstly, phagocytosis of pHrodo was unaffected by presence of TLR4, JAK1/2 or 207 TBK1 inhibitors (Fig.6A) . Secondly, binding/ingestion of pHrodo triggered expression of 208 TNFa, IL-6 and IL-8 that was abrogated after TLR4 inhibition but not by inhibition of the 209 IFN signalling pathway (Fig.6B ). This was confirmed by a IRF3, NFkB translocation assay 210 ( Fig.6C) . These data clearly show that pHrodo triggers strong immune response in MDM that 211 can be prevented by TLR4 inhibition. Treatment of MDM with pHrodo induced potent HIV-212 1 inhibition that was accompanied by G0 arrest and SAMHD1 activation/dephosphorylation 213 at T592 (Fig.6D,E ) 214 Importantly, TLR4 blockade was able to rescue cell cycle changes/SAMHD1 215 phosphorylation and HIV-1 infection but neither RUXO or TBK1 inhibitor BX795 could 216 restore infection and cell cycle changes, phenocopying experiments with LPS alone (Fig.2) . 217
However, when we measured cell cycle associated transcripts (Fig.6F ) there were several 218 significant differences between LPS and E. coli mediated TLR4 activation. Firstly, p16 was 219 significantly increased and cycA2 decreased. Both these transcripts were unchanged after 220 IFN signalling inhibition suggesting they are IFN-independent changes (Fig.6F, compare Here we have reported three key novel observations. Firstly, G0 arrest occurs in primary 231 human macrophages after exposure to pathogen via TLR4. Secondly, it is MyD88 and thus 232 an NFkB independent phenomenon. Thirdly, G0 arrest is mediated through two independent 233 pathways, one of which is IFN-dependent and the other IFN-independent. 234 235 Our previous work had shown that human monocyte derived macrophages (MDM) can re-236 enter cell cycle from their G0 state 19,21 . Once the cells enter cell cycle they are permissive to 237
HIV-1 infection. We took advantage of this experimental model to investigate whether the 238 cell cycle is involved in HIV-1 restriction after TLR4 activation. Indeed, TLR4 activation 239 caused G0 arrest that correlated with SAMHD1 activation and HIV-1 restriction in 240 macrophages. Moreover, this arrest and subsequent blockade to HIV-1 infection cannot be 241 simply overcome by blocking IFN signalling. Demonstrating that IFN is not the major driver, 242 but one of two independent mediators of HIV-1 restriction after TLR4 activation is an 243 important finding. 244
245
The effect of LPS on G0 arrest has been shown in mouse primary cells and murine cell lines 246 31, 32 or in the human cell line, THP-1/U937 33,34 . Despite these reports, surprisingly little is 247 known about the mechanism how LPS causes G0 arrest. It has been suggested that production 248 of ROS or DNA damage can play role 34, 35 . Our data suggest that neither ROS nor DNA 249 damage seems to be responsible for G0 arrest in human MDM (Fig.S2, S3 ). 250
251
We speculate that mitogen activated protein kinase kinases may play role in the mechanism. 252
We have shown previously that cell cycle re-entry from G0 to G1 state is mediated by 253 MEK/ERK kinases. These kinases can be activated by TLR4 activation in a MyD88-254 dependent and independent manner 36,37 . Even though it might seem to be counter intuitive as 255 our previous observations show that activation of MEK/ERK leads to cell cycle re-entry not 256 to G0 arrest in MDM 19 , it has been suggested that prolonged exposure to LPS can 257 downregulate phosphorylation (activation) of these kinases 38 , possibly leading thus to G0 258 transition. Another possibility is that strong TLR4 activation triggers an apoptotic program in 259 the cells and G0 arrest is first step to apoptosis and cell death 39 . However, we do not see 260 extensive reduction in cell numbers even 5 days post-LPS treatment (Fig.S3D ), suggesting 261 survival of activated macrophages. is not surprising as many IFN-inducible proteins with HIV-1 restriction potency have been 280 shown 40 and may play additional roles in this restriction. These data confirm that SAMHD1 281 is major player in LPS mediated HIV-1 restriction. 282 283 Importantly we have also shown that E. coli leads to G0 arrest in human macrophages and 284 this arrest cannot be rescued by blocking IFN signalling. Remarkably however, inhibition of 285 TLR4 was able to prevent the G0 arrest and SAMHD1 phosphorylation. This suggests that 286 whole gram-negative bacteria also activate two independent pathways to induce G0 arrest. 287 288 Why would macrophages regulate their cell cycle? Macrophages contribute to innate 289 immunity via phagocytosis, antigen presentation but they are also secretory cells vital to the 290 regulation of immune responses and development of inflammation. One can imagine that cell 291 division of macrophages would benefit the host by increasing the number of effector cells at 292 the centre of infection. But at the same time the division of infected cells harbouring live 293 pathogen could also lead to doubling of infected cells, an event that can potentially harm the 294 host. Even though our previous work showed that MDM re-enter cell cycle without 295 measurable cell division 19 , many tissue resident macrophages can proliferate 41 and thus 296 could use G0 arrest as a response to danger signal to stop division and contain infection. 297 298 It is also possible that cell cycle changes are necessary for activation of non-cycling function 299 of cell cycle associated proteins. G0 or G0 arrested cells will increase expression of e.g. p14, 300 p16, p21 or p27 proteins. It has been shown that cell cycle regulators can serve non-cycling 301 functions in innate immunity. It has been suggested that CDK activity is required for IFN-b 302 production 42 , which in turn initiates immune system activation. Nevertheless, these 303 experiments still await validation by specific CDK knockdowns. It has been shown that p21 304 supress IL-1b 43 , or that p16 inhibits macrophage activity by degradation of interlukin-1 305 receptor and thus impairs IL-6 production that can lead to tissue inflammation reduction 44 . 306 Moreover, p27 seems to have a unique role in macrophage migration 45 . It is thus conceivable 307 that cell cycle regulators can contribute to maintenance of balanced responses to immune 308 stimuli. 309
The concept that immune system can be manipulated by the host cell cycle has therapeutic 310 implications and establishes a new paradigm for understanding not only basic cell biology but 311 may present new ways to treat infectious disease but possibly also autoimmune diseases and 312 cancer. 313
314
The relevance of macrophage G0 arrest by LPS may be in relevant in HIV pathogenesis 315 where macrophages may be exposed to gut derived LPS during inflammation in the acute or 316 chronic phase of HIV. These macrophages are likely arrested with SAMHD1 317 dephosphorylated at T592, and thereby rendered resistant to HIV-1. T cells would remain 318 more susceptible as they do not express TLR4 and are less sensitive to IFN, consistent with 319 observed high levels of viral turnover in GALT associated CD4 T cells. 320
321
In summary, our data show that TLR4 activation regulates the cell cycle in human primary 322 macrophages after exposure to immune stimuli or pathogen. We also show evidence that 323 TLR4 activation by bacterial LPS can mediate HIV-1 inhibition through regulation of 324 SAMHD1 phosphorylation in a MyD88-independent manner by two pathways: (i) IFN 325 dependent pathway and (ii) IFN-independent pathway accompanied by p21 upregulation and 326 SAMHD1 dephosphorylation. Together, these data suggest that macrophages can rapidly 327 achieve an anti-viral state by activation of TLR4 and G0 arrest prior to IFN secretion, thereby 328 demonstrating redundancy and highlighting the importance of cell cycle regulation as a 329 response to danger signals. Finally, interferon independent activation of SAMHD1 by TLR4 330 represents a novel mechanism for limiting the HIV-1 reservoir size and should be considered 331 for host-directed therapeutic approaches that may contribute to curative interventions. 
